LBI-RUD will provide funding and working space for seven years and up to 15 persons. The physical location of LBI-RUD will be within the medical campus, at the intersection of biomedical research and clinical treatment, where all three partner institutions (CeMM, MedUni Vienna and CCRI) are located, to maximize synergies and to enable truly translational research activities.

Rare diseases represent a tremendous challenge to current healthcare systems. Though any rare disease, by definition, affects fewer than 1 in 2,000 people, collectively there are >7,000 rare diseases affecting up to 5% of the European population, often with chronic, debilitating and life-threatening consequences. In recognition of their burden to human health, the EU has made rare diseases a major priority of its health-related activities. Rare diseases are paradigmatic for the upcoming era of personalized and participatory medicine, and LBI RUD will broadly embrace their pioneering role for the future of medicine. Through close coordination with CeRUD, the Vienna Center for Rare and Undiagnosed Disease, LBI-RUD will establish a platform for efficient interaction with national and international institutions to disseminate knowledge on rare diseases.

Ludwig Boltzmann Gesellschaft:
The Ludwig Boltzmann Gesellschaft is a non-university sponsor organization for research institutes with a focus on the health science. Its defining features are strong interdisciplinary and transdisciplinary research, and the translational nature of its research institutes. Partners from academia and the private and public sectors collaborate to develop coherent research programmes. Funding is provided by the partners and the Boltzmann Gesellschaft for a start-up and development phase lasting seven years.
http://www.lbg.ac.at/

Kaan Boztug:
Kaan Boztug studied Medicine in Düsseldorf, Freiburg and London. He worked as a graduate student with Iain Campbell at the Scripps Research Institute, followed by clinical and postgraduate research training with Christoph Klein at Hannover Medical School. He joined CeMM as Prinicpal Investigator in 2011 and holds a dual appointment as Associate Professor at the Department of Pediatrics and Adolescent Medicine at the Medical University of Vienna. Kaan Boztug is also Director of CeRUD, the Vienna Center for Rare and Undiagnosed Diseases.
http://www.cemm.oeaw.ac.at/research/groups/kaan-boztug-group/